NORTH CHICAGO (dpa-AFX) - Abbott Laboratories (ABT) Monday announced FDA clearance for two new over-the-counter continuous glucose monitoring systems - Lingo and Libre Rio.
Abbott said, these two systems are based on its FreeStyle Libre continuous glucose monitoring technology.
Lingo is a consumer biowearable and is designed for general consumers who are looking to improve their overall health and wellness, while Libre Rio is designed for adults with Type 2 diabetes, who do not use insulin and manage diabetes through lifestyle modifications.
The Lingo system combines a biosensor that is worn on the upper arm for 14 days. Libre Rio is the first over-the-counter continuous glucose monitoring system with a measurement range of 40-400 mg/dL.
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
© 2024 AFX News
